Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
Dollar change
Percentage change
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-9.44% Shs Outstand Perf Week8.31%
SponsorGlobal X ETF Type Tagsequity Return% 3Y-22.37% Total Holdings45 Perf Month7.33%
Fund Family Bond Type Tagshealthcare Return% 5Y-5.48% AUM83.29M Perf Quarter3.58%
IndexSolactive Genomics Index Average Maturity Tagsbiotechnology Return% 10Y NAV% Perf Half Y-3.01%
Index Weighting Commodity Type Tagsgenomics Return% SI NAV/sh Perf Year-9.44%
Active/Passive Quant Type Tags- Flows% 1M-18.77% 52W Range8.63 - 12.58 Perf YTD-2.49%
Dividend TTM- ESG Type Tags- Flows% 3M-18.77% 52W High-10.40% Beta1.12
Dividend Ex-DateDec 30, 2021 Dividend Type Sector/Theme Flows% YTD-12.38% 52W Low30.59% ATR (14)0.23
Expense0.50% Structure Type Region Flows% 1Y RSI (14)69.85 Volatility1.81% 1.74%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.83 Prev Close11.04
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume56.15K Price11.27
SMA207.28% SMA507.50% SMA2005.83% Trades Volume46,684 Change2.08%
Jan-26-22 01:38PM
Jan-20-22 09:38AM
Jan-13-22 01:38PM
Nov-25-20 03:37PM
Aug-27-20 05:31PM
04:00AM Loading…
Jun-08-20 04:00AM
Jun-04-20 12:20PM
May-26-20 12:50PM
Jan-09-20 11:13AM
Dec-26-19 02:30PM
Dec-18-19 01:41PM
Dec-12-19 08:00AM
Dec-04-19 10:23PM
Nov-29-19 12:15PM
06:55PM Loading…
Nov-25-19 06:55PM
Nov-21-19 12:15PM
Oct-30-19 10:43AM
Oct-10-19 09:25AM
Sep-06-19 03:07PM
Sep-04-19 03:18PM
Aug-05-19 12:00PM
Aug-01-19 12:10PM
Jun-24-19 12:17PM
Jun-19-19 11:15AM
Apr-15-19 02:00PM
Apr-11-19 02:18PM
Apr-10-19 08:01AM
Apr-09-19 05:15PM
10:03AM Loading…
Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.